<VariationArchive VariationID="183394" VariationName="NM_004064.5(CDKN1B):c.-454_-451del" VariationType="Deletion" Accession="VCV000183394" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2017-05-12" MostRecentSubmission="2024-01-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="181498" VariationID="183394">
      <GeneList>
        <Gene Symbol="CDKN1B" FullName="cyclin dependent kinase inhibitor 1B" GeneID="1027" HGNC_ID="HGNC:1785" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="12717368" stop="12722369" display_start="12717368" display_stop="12722369" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="12870301" stop="12875304" display_start="12870301" display_stop="12875304" Strand="+" />
          </Location>
          <OMIM>600778</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1B">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC130007457" FullName="ATAC-STARR-seq lymphoblastoid active region 6026" GeneID="130007457" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="12717342" stop="12717391" display_start="12717342" display_stop="12717391" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_004064.5(CDKN1B):c.-454_-451del</Name>
      <CanonicalSPDI>NC_000012.12:12717383:CCTTCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="12717384" stop="12717387" display_start="12717384" display_stop="12717387" variantLength="4" positionVCF="12717383" referenceAlleleVCF="CCCTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="12870318" stop="12870321" display_start="12870318" display_stop="12870321" variantLength="4" positionVCF="12870317" referenceAlleleVCF="CCCTT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.12870320_12870323del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.12870320_12870323del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.12717386_12717389del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.12717386_12717389del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016341.1" sequenceAccession="NG_016341" sequenceVersion="1" change="g.5019_5022del">
            <Expression>NG_016341.1:g.5019_5022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004064.5" sequenceAccession="NM_004064" sequenceVersion="5" change="c.-454_-451del" MANESelect="true">
            <Expression>NM_004064.5:c.-454_-451del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA186092" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600778.0005" DB="OMIM" />
        <XRef Type="rs" ID="786201010" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004064.5(CDKN1B):c.-454_-451del AND Multiple endocrine neoplasia type 4" Accession="RCV000162208" Version="7">
        <ClassifiedConditionList TraitSetID="2430">
          <ClassifiedCondition DB="MedGen" ID="C1970712">Multiple endocrine neoplasia type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-05-12" MostRecentSubmission="2024-01-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23555276</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2430" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Multiple endocrine neoplasia type 4</ElementValue>
                <XRef ID="MONDO:0012552" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV</ElementValue>
                <XRef Type="MIM" ID="610755" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MEN4</ElementValue>
                <XRef Type="MIM" ID="610755" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17275" />
                <XRef ID="17275" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37733893</ID>
                <ID Source="BookShelf">NBK594826</ID>
              </Citation>
              <XRef ID="276152" DB="Orphanet" />
              <XRef ID="C1970712" DB="MedGen" />
              <XRef ID="MONDO:0012552" DB="MONDO" />
              <XRef Type="MIM" ID="610755" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="383269" SubmissionDate="2017-05-09" DateLastUpdated="2024-01-26" DateCreated="2015-03-16">
        <ClinVarSubmissionID localKey="600778.0005_MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" title="CDKN1B, 4-BP DEL, -456CCTT_MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" />
        <ClinVarAccession Accession="SCV000212165" DateUpdated="2024-01-26" DateCreated="2015-03-16" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 62-year-old woman with multiple endocrine neoplasia type IV (MEN4; 610755), Occhi et al. (2013) identified a heterozygous 4-bp deletion (c.-456_-453delCCTT) in a highly conserved region in the 5-prime untranslated region of the CDKN1B gene. The mutation was not found in the dbSNP or 1000 Genomes Project databases or in 600 control chromosomes. The deletion shifted the upstream open reading frame (ORF) termination codon, thus lengthening the upstream ORF-encoded peptide from 29 to 158 amino acids and shortening the intracistronic space from 429 to 38 bp, with a possible negative influence on translation reinitiation from the main ATG. This change was predicted to prevent proper functioning of the 40S ribosomal subunit during translation. Patient cells showed normal levels of mutant mRNA, but decreased expression of the p27 protein, with weak cytoplasmic staining. Pancreatic tumor cells from the patient showed weak cytoplasmic p27 staining; there was no loss of heterozygosity for the wildtype allele. In vitro functional cellular expression assays showed that the 4-bp deletion impaired translation of a reporter gene by affecting translation reinitiation. The findings elucidated a novel mechanism by which p27 levels can be modulated by changes in the upstream ORF. The patient had acromegaly and a well-differentiated nonfunctioning pancreatic endocrine neoplasm.</Attribute>
              <Citation>
                <ID Source="PubMed">23555276</ID>
              </Citation>
              <XRef DB="OMIM" ID="610755" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN1B" />
          </GeneList>
          <Name>CDKN1B, 4-BP DEL, -456CCTT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, -456CCTT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600778.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="383269" TraitType="Disease" MappingType="Name" MappingValue="MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" MappingRef="Preferred">
        <MedGen CUI="C1970712" Name="Multiple endocrine neoplasia type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

